Order Entry
United States
ContactUsLinkComponent
Human Recombinant CCL19 (MIP-3 beta)
Human Recombinant CCL19 (MIP-3 beta)
Catalog # MSPP-100-0935
CAS Number:  
undefined
Human Recombinant CCL19 (MIP-3 beta)
Catalog # MSPP-100-0935
Supplier Number:  100-0935
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.

Specifications

  • Protein/Peptide Type:
    Recombinant
  • Species:
    Human
  • Size:
    100 µg
  • Protein Synonyms:
    beta-chemokine exodus-3|CC chemokine ligand 19|ELC|Exodus-3|MIP-3β|SCYA19
  • Protein/Peptide Name:
    CCL19 (MIP-3 beta)
  • Purity:
    ≥95%
  • Cat. No.:
    MSPP-100-0935

Specifications

About this item

Chemokine ligand 19 (CCL19), also known as macrophage inflammatory protein-3 beta (MIP-3β), is a member of the CC chemokine family, which plays key roles in inflammatory responses, T cell activation, homeostasis, and development (Yan et al.). CCL19 is expressed in lymph nodes, thymus, and activated bone marrow stromal cells; it binds to C-C motif chemokine receptor 7 (CCR7) to induce migration of macrophages, T cells, and B cells (Gibejova et al.). Clinically, the expression of CCL19 is correlated to autoimmune diseases such as rheumatoid arthritis and cancer (Pickens et al.; Zhang et al.).

Caution: Product restrictions: (i) Customer shall not make products or any portion of them in any way, shape or form, including as a component of another product available for the purpose of further resale or alter or remove the Product label and the Supplier’s mark of origin without express written permission of Supplier and (ii) Customer is familiar with Supplier’s restrictions on the use of the products and shall use the products in compliance with such restrictions and the applicable Supplier Product Information sheet (collectively, the 'Product Restrictions').